Teleflex Incorporated
NYSE:TFXMedical - Instruments & Supplies
+$1.04 today
- Market cap
- $6.58B
- Beta
- 0.82
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$22.79
- Dividend yield
- 1.08%
Volume 1.16M
Average 0.80M
TFX EBITDA Margin
EBITDA as a percentage of revenue.
Teleflex IncorporatedNYSE: TFX
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin narrows to 21.6%
EBITDA Margin was 21.6% in Q2 FY2026, down 7.0 pp from a year earlier. On a trailing-twelve-month basis it was -6.1%, down 25.9 pp year over year. Over 3 fiscal years it narrowed by 11.0 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 9 analysts of 33.1% for the fiscal year ending Dec 2026, up from 15.2% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 21.6%+16.8 pp QoQ
- Last fiscal yearDec 2025
- 15.2%+1.0 pp YoY
- LTMJun 2026
- -6.1%-25.9 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -7.0 pp | +68.7 pp | +75.7 pp |
| 1 year | +1.0 pp | +17.9 pp | +16.9 pp |
| 3 years | -11.0 pp | +20.4 pp | +31.4 pp |
| 5 years | +27.7 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 15.2%
- Year-over-year change
- +1.0pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 15.2% | +1.0pp |
| FY2024 | 2024-12-31 | 14.2% | -11.4pp |
| FY2023 | 2023-12-31 | 25.6% | -0.6pp |
| FY2022 | 2022-12-31 | 26.2% | -4.2pp |
| FY2021 | 2021-12-31 | 30.4% | — |
EBITDA Margin vs competitors
How TFX compares with its peers on the latest reported figures
- TFX's LTM Jun 2026 EBITDA Margin of -6.1% is the 8th highest of the 10 companies compared; the peer median is 17.2%.
- Its year-over-year change of -25.9 pp is the 7th highest of 10, against a peer median of -2.8 pp.
- Over three fiscal years its change of -11.0 pp compares with a peer median of +11.6 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 49.9% | -0.2 pp | — | |
| LTM Jun 2026 | 24.3% | -2.8 pp | -0.4 pp | |
| LTM Sep 2026 | 21.3% | -0.4 pp | +7673.7 pp | |
| LTM Sep 2026 | 21.2% | -0.0 pp | +6.2 pp | |
| LTM Jun 2026 | 17.2% | -30.5 pp | +103.9 pp | |
| LTM Jun 2026 | 13.9% | +4.5 pp | -5.4 pp | |
| LTM Sep 2026 | 10.2% | -18.5 pp | +17.0 pp | |
| LTM Jun 2026 | -6.1% | -25.9 pp | -11.0 pp | |
| LTM Sep 2026 | -133.9% | -153.8 pp | -60.9 pp | |
| LTM Sep 2026 | -1917.5% | -679.9 pp | +127741.9 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding TFX) | 17.2% | -2.8 pp | +11.6 pp | |
Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.81B | 2.79B | 2.97B | 3.05B | 1.99B |
| Cost of Revenue | 1.26B | 1.26B | 1.33B | 1.34B | 871.96M |
| Gross Profit | 1.55B | 1.53B | 1.65B | 1.7B | 1.12B |
| Gross Margin | 55.2% | 54.9% | 55.4% | 55.9% | 56.2% |
| Research & Development | 130.84M | 153.82M | 154.35M | 161.67M | 144.78M |
| Selling, General & Admin | 860.09M | 863.75M | 929.87M | 995.27M | 720.17M |
| Operating Expenses | 921.51M | 1.03B | 1.14B | 1.55B | 864.95M |
| Depreciation & Amortization | 237.36M | 230.59M | 242.12M | 274.6M | 177.74M |
| EBITDA | 853.8M | 730.77M | 761.21M | 433.62M | 302.51M |
| EBITDA Margin | 30.4% | 26.2% | 25.6% | 14.2% | 15.2% |
| Operating Income | 628.1M | 499.73M | 506.31M | 151.01M | 255.8M |
| Operating Margin | 22.4% | 17.9% | 17.0% | 5.0% | 12.8% |
| Interest Income | 1.33M | 912K | 12.78M | 8.01M | 6.4M |
| Interest Expense | 56.97M | 54.26M | 85.08M | 83.54M | 100.22M |
| Other Income / Expenses | (68.63M) | (53.81M) | (72.3M) | (75.54M) | (231.25M) |
| Income Before Tax | 559.47M | 445.92M | 434.01M | 75.48M | 24.55M |
| Pre-Tax Margin | 19.9% | 16.0% | 14.6% | 2.5% | 1.2% |
| Income Tax Expense | 74.35M | 83M | 76.44M | 5.32M | (33.98M) |
| Net Income | 485.37M | 363.14M | 356.33M | 69.68M | (905.64M) |
| Net Margin | 17.3% | 13.0% | 12.0% | 2.3% | -45.4% |
| EPS (Basic) | 10.38 | 7.74 | 7.58 | 1.49 | (20.30) |
| EPS (Diluted) | 10.23 | 7.68 | 7.53 | 1.48 | (20.25) |
| Weighted Avg Shares | 46.77M | 46.9M | 46.98M | 46.84M | 44.62M |
| Weighted Avg Shares (Diluted) | 47.43M | 47.31M | 47.3M | 47.09M | 44.72M |
Teleflex Incorporated
NYSE:TFX
Intrinsic Alpha fair value
Locked
Current Price
$165.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.